Latest Regulatory Compliance News

Ovanti appoints two early Afterpay executives to its Advisory Board as it prepares to relaunch its BNPL platforms IOUPAY and myIOU, targeting rapid growth in Southeast Asia and beyond.

ECS Botanics delivered a fourth consecutive quarter of positive operating cash flow in Q4 FY26, with a full-year turnaround of $5.9 million. The company’s branded B2C revenue surged 31% year-on-year, supported by product launches and European market expansion.

Lodestar Minerals has responded to an ASX query over the late filing of director interest notices, attributing the delay to an administrative oversight during an option conversion process. The company has updated its procedures to prevent future lapses.

Samuel Holdings has agreed not to trade its shares in DGR Global without Takeovers Panel approval, locking in its stake during ongoing proceedings sparked by Jeremy Raper's application.

MotorCycle Holdings has uncovered leave loading underpayments affecting current employees since 2020, with remediation costs estimated up to $1.3 million. The company is voluntarily engaging the Fair Work Ombudsman while conducting a complex review of historical payroll compliance.

Ausgold Limited has cleared significant regulatory hurdles for its Katanning Gold Project, with Western Australia’s EPA approving the Environmental Review Document for public release and three new mining leases granted, paving the way for a final investment decision by late 2026.

Richmond Vanadium Technology has appointed Seth McCann as General Manager for Development, Approvals & Studies, positioning the company to advance critical environmental and regulatory milestones for its Queensland vanadium project.

VRX Silica has raised $4.5 million through strategic equity placements with US-based Nebari Partners and existing shareholder Delphi group, bolstering institutional backing ahead of key project financing milestones for its Arrowsmith North silica sand project.

The Federal Treasurer has barred three foreign shareholders from exercising voting rights in Northern Minerals due to non-compliance with mandated share divestments, intensifying regulatory oversight amid ongoing FIRB investigations.

Paradigm Biopharmaceuticals has secured US$3 million in its latest tranche under a US$27 million convertible note facility, bolstering funding for its global Phase 3 trial of injectable pentosan polysulfate sodium in knee osteoarthritis.

Klevo Rewards has successfully completed a 14-day commercial trial of its stablecoin transaction platform, generating approximately USD 1.22 million in gross revenue and validating its payment capabilities.

The U.S. Department of Justice has reinforced Dateline Resources' legal standing to continue mining at the Colosseum Project, opposing environmental group claims that challenge the existing Plan of Operations.